We have improved the method of measuring dioxins in the blood of Yusho patients; with this improved method, it is possible to take measurements quickly and precisely, using as little as 5g of blood. The specific points of improvement of this method are the extraction of lipids from blood by accelerated solvent extractor (ASE), the miniaturization of column cleanup for the purification of dioxins, and the use of a solvent cut large volume (SCLV) injection system with high-resolution gas chromatography/high-resolution mass spectrometry (HRGC/HRMS). Using this improved method of analysis, we are currently investigating dioxins in the blood of 400 Yusho patients collected in Japan in 2002. We here describe the details of our announcement at Dioxin 2002 Symposium about the improvement of this analysis method, and discuss several other modifications 1) .
Introduction
In order to understand the influence of dioxins on human health, it is necessary to investigate the body burden produced by these chemicals. We have previously reported a significant correlation between the dioxin concentrations in blood and that in tissues (subcutaneous adipose tissue, mesentery fat, liver, kidney, muscles, brain, spleen), and have noted that the dioxin concentrations in blood lipids have almost the same level as the concentrations in fat tissues 2, 3) . Dioxins in the blood of municipal incinerator plant laborers and people who live near factories have been investigated in Japan for several years 4, 5) . However, this research has been limited since it was necessary to extract at least 100 ml of blood for evaluation. In order to conduct extensive research on human contamination by dioxins, an analytical method which can accurately detect dioxins from much smaller samples of blood is required.
Additionally, such a method would be helpful for measuring dioxins in patients who cannot safely provide large samples of blood. We have been studying concentrations of dioxins (PCDDs, PCDFs and coplanar PCBs) in blood samples from Yusho patients afflicted with disease due to PCDF poisoning that occurred in western Japan in 1968. Since most of those afflicted at that time are now over 60 years old, they can safely supply only small volumes of blood for determination of dioxin concentrations. Therefore, in order to reduce the physical burden on patients, it is necessary to develop a highly sensitive analytic method that can accurately evaluate dioxin concentrations from blood samples of only 5 g. Furthermore, the pretreatment procedure of dioxins in the blood is very complicated and time-consuming. In this study, we developed an analytic method for measuring dioxin concentrations in blood samples as small as 5 g using high resolution gas chromatography/high resolution mass spectrometry (HRGC/HRMS) equipped with a solvent cut large volume (SCLV) injection system as a large volume injection technique, and examined efficient methods of speeding up the pretreatment procedure for blood samples and reducing background levels such that they do not affect the measurement of dioxins. Using this method, we measured dioxins in blood samples collected in 2001 from 78 Yusho patients who live in Fukuoka 1) .
Experiments
Lipid was extracted from the blood samples by an accelerated solvent extractor (ASE-200, Dionex, Sunnyvale, CA). Each blood sample was accurately weighed to 5 g and mixed with 4 g Isolute (International Sorbent Technology Ltd., Hengoed, Mid Glamorgan, UK). After the extraction cell was filled, the 13 C-labeled internal standards were added and extracted by ASE for 10 minutes × 2 times with acetone/ hexane (1:4, v/v) under pressure (2000 psi) and temperature (150°C). The extract was concentrated to dryness after treatment with anhydrous sodium sulfate, and the lipid contents were determined gravimetrically. An extracted lipid was used to carry out cleanup at a scale one-fourth that of the conventional method (Fig. 1) . The column packing (silver nitrate silica gel, active carbon and anhydrous sodium sulfate) used in this experiment were washed by ASE with hexane or toluene. Dioxin concentrations were measured using HRGC/HRMS equipped with an SCLV injection system (SGE Australia). The setting conditions are summarized in Tables 1, 2 .
Results

1)
The sensitivity of GC/MS with the SCLV injection system was increased to 10 times the level of the classical method (Fig. 2, 3) .
2) When the lipid was extracted from the blood by ASE with acetone/hexane (1:4, v/v) as the solvent, the lipid contents and dioxin concentrations were nearly equal to those found by the conventional method (Table 3) .
3) Using the present method, the concentrations of dioxin isomers in the 5 g blood samples from 8 normal subjects were almost equal to those found by the conventional method using 20 g samples of the same blood (Fig. 4) .
4) The present method demonstrated high reproducibility based on experiments conducted using the same blood samples (Fig. 5) .
5) The improvement of the pretreatment method made it possible to sufficiently reduce background levels such that they do not affect the measurement of dioxins (Table 4) .
6) The recovery of the 13 C-labeled internal standards was 60% overall when the dioxin concentrations in the blood of 78 Yusho patients were measured (Table 5) . 
Fig. 2. HRGC/HRMS chromatogams of PCDDs in human blood.
A: Normal injection 2 µl/10 µl (equivalent to 10 g blood). B: SCLV injection 5 µl/10 µl (equivalent to 2.5 g blood).
Discussion
These results indicate that the present method is the most effective for accurately measuring dioxin concentrations using a blood volume of only 5 g. Moreover, this method allows many samples to be treated in a short period of time with high reproducibility in comparison with the conventional method.
We would like to offer additional details about out method. As stated above, our analytic method provides high sensitivity detection of dioxins by ASE extraction, miniaturization of column cleanup, and the adaptation to GC/MS of the SCLV system. All of the above are existing technologies related to dioxin analysis, and indeed, sample analysis of the environment by ASE extraction has previously been reported [6] [7] [8] [9] . Miyata et al. 10) have reported on miniaturization of column cleanup, and similarly, Matsumura et al. 11) and Masuzaki et al. 12) discussed the application of the SCLV system for dioxin measurement in human blood. We believe that our method is not only rapid but also highly effective and sensitive, and is therefore of great use in examining and following up Yusho patients. For these patients in particular, it is necessary that GC/MS should be able to detect very small quantities of dioxins (1-10 fg) in 5 g of blood samples, and that the blank level should be fully low compared with the dioxin level in the blood. First, we equipped GC/MS with SCLV injection system in order to achieve the greatest possible detection sensitivity by GC/MS. By this method, a sample injection volume of 10 µl in 15 µl or 5 µl in 10 µl was attained; that is, an injection volume of 1/2 to 2/3 of a sample is possible, 5 to 10 times the sample injection volume obtained using the traditional method in which a sample injection volume of 1-2 µl in 20 µl is used. This is almost the same as a 2 µl manual injection in a concentrated sample of 5 µl. There is great merit even in this case, in which an automatic injection system can be used. Furthermore, since almost all solvents can be removed, the sample injection volume to an analysis column may be very small, and, since most matrices can be removed not only for a solvent but also for a remarkable coexistence substance in a pre-column, a narrow bore (0.1 to 0.15 mm) and thin film thickness column (0.1 to 0.15 µm) can be used. Removing the solvents and matrices makes it possible to obtain a very sharp peak and raises the S/N ratio. Therefore, the MS state can be kept very stable by removing solvents and matrices in a pre-column stage. Moreover, by using the small analysis column of the inner diameter, career gas is kept low and the inside of the MS can be maintained as a high vacuum. It is reasonable to expect that high sensitivity can thus be maintained by maintaining a high vacuum with the improvement of the S/N ratio as stated above.
A blank level can result from one of three sources: mixed contaminants which originate primarily in a reagent, contaminants adhering to the instruments, and contaminants found in the analysis operation environment. Reagents of guaranteed high purity are now available for dioxin analysis; additionally, reagents and other substances which are used as a column filling are able to perform washing and purification effectively in a solvent using the ASE or a Soxhlet extraction. We can reasonably reduce the contamination to take place using this method due to the miniature size of one-fourth of the amount formerly used during cleanup (in this procedure, the net of silver nitrate and active carbon to be used are only 50 mg and 0.5 mg, respectively).
Concerning the instrument blank, the contaminants adhering to the inside of glassware instruments were decreased by miniaturizing the glassware implements. All glassware implements removed the organic matter by overnight dipping in chromic acid mixture. It was used by acetone and hexane just before use.
In order to reduce the blank due to contamination from analysis operation, we prepared the special laboratory for human blood samples which distinguished from the laboratories concerns environmental samples (sediments, fly ash, soil, waste, etc.). The extraction operation was completed by the sealing system using an ASE extraction machine, so the contaminants mixed during lipid extraction decreased. Our current research focuses on measuring the dioxins in the blood of approximately 400 Yusho patients sampled throughout Japan in 2002. Because the number of cases to be analyzed increased 5 times over the previous year when the study area was smaller, the analyzing method was improved as follows, and the following countermeasures were devised: 1) HRGC/HRMS equipped with an SCLV system was installed exclusively for blood analysis.
2) The silver nitrate silica gel column and the activated carbon column were linked directly.
3) After freeze-drying blood, lipid in blood was extracted by ASE at 2,000 psi and 150°C, and using acetone/hexane (1:3, v/v). The extraction liquid was able to be produced the required concentrations and dryness, and it was also possible to obtain the lipid content. Since dryness by the anhydrous sodium sulfate of the extraction liquid was excluded, disturbance of the contaminant mixed from a reagent and an instrument was decreased.
4) The analysis laboratory for blood was used exclusively for this purpose and the possibility of contaminants intruding during operation was therefore reduced.
Instead of washing glassware implements with a chromic acid mixture, they were washed with detergent before being heated to 450°C overnight, cooled and used for analysis. This washing method is able to remove contaminants from the glassware implements, therefore it not only eliminates the danger posed by the chromic acid mixture, but also makes unnecessary the washing procedure with hexane and acetone.
Considerations for Future Research
As shown in Table 3 , when HpCDD and OCDD in blood are extracted by ASE, they show high concentrations compared with those obtained by the conventional method. Although the cause of this is not clear, it is possible that these compounds are not fully extracted from blood by the traditional method. Since the toxicity equivalency factors (TEF) of these compounds are small at 0.01 and 0.0001, respectively, they do not have significant influence in the total toxicity equivalent (TEQ) with this phenomenon. Nevertheless, it remains to be clarified in the future. It is important to introduce an automatic cleanup system for blood dioxin analysis because it is critical to develop a quick, effective and reliable method for measuring dioxins in blood.
The proposed method of analyzing dioxins in blood is expected to be useful not only in research on Yusho but also to investigate the other cases of patients affected by dioxin contamination. We have already used this method to measure dioxins in serum samples from patients who experienced a toxic hot spot in Vietnam. We have also measured the dioxins in the umbilical cord blood (20 g) of four subjects by this method, and found that the average value of 2, 3, 7, 8-TCDD concentrations was 0.0015 pg/g with a range of 0.001-0.002, and that these values were 1/9-1/2 the values found for each mother's body blood 13) . Greater sensitivity of GC/MS instruments is necessary in order to determine the dioxins in umbilical cord blood with higher accuracy. We believe that it is possible to obtain 2 to 3 times greater sensitivity of GC/MS by adjusting the column conditions (inner diameter, film thickness, etc.) of GC, and the conditions of MS.
Moreover, we have previously reported that the SCLV injection system can be used with a polar SP2330 column, and that dioxins can be separated using a similar method 14) . Such a method would also be applicable not only to blood dioxin analysis but also to analysis of food and environmental samples 15) .
